Jaya Lakshmi Thangaraj, Edith Lopez, Kevin Tharp, Dan Kaufman. "Engineered iPSC-derived NK cells targeting the SIGLEC7-glyco-immune checkpoint improves anti-tumor activity in solid cancers." Blood, 2025. doi:10.1182/blood-2025-5913